The CDSCO Rules for New Drugs 2025 have officially come into effect, marking a major reform in India’s pharmaceutical regulatory framework. The Central Drugs Standard Control Organisation (CDSCO) has overhauled its drug approval process to reduce delays, promote innovation, and ensure faster availability of life-saving medications to the Indian population. The government has introduced automated … Read more
The Pharma Manufacturing Hubs 2025 initiative is transforming India’s pharmaceutical production landscape with state-of-the-art industrial clusters across the country. Under the Atmanirbhar Bharat and Pharma Vision 2047 programmes, the Government of India has announced the operational rollout of several new pharmaceutical manufacturing hubs aimed at boosting exports, generating employment, and strengthening drug security. These dedicated … Read more
The Government of India has officially launched the Pharma Innovation Fund India 2025, allocating ₹1500 crore to fuel pharmaceutical research and development across the country. This strategic initiative is aimed at boosting India’s self-reliance in drug discovery, biotechnology, and formulation sciences. As a part of the Department of Pharmaceuticals’ Vision 2047 roadmap, this fund is … Read more
India continues to solidify its position as the pharmacy of the world with remarkable progress in Pharma Export India 2025. The country has seen a sharp rise in exports of pharmaceutical formulations, bulk drugs (APIs), and biotechnology products, crossing new trade milestones in global markets. According to the Ministry of Commerce and Industry, India’s pharmaceutical … Read more